Skip to main content
Year archive

Checkpoint Trends Limited — 2021 filings

All 22 regulatory filings released by Checkpoint Trends Limited (531099) in 2021, sourced directly from the official regulator.

22 Filings
2021 Period
2021 filings (22)
Filing Released Lang
Newspaper publication of Unaudited Financial Results for the quarter and half year ended September 30, 2021
Regulatory Filings
2021-11-16 English
Disclosure of Related Party Transactions for the half year ended September 30, 2021
Regulatory Filings
2021-11-11 English
Standalone Unaudited Financial Results along with limited review report, Asset and liability statement and Cash Flow Statement of the Company for the quarter and half year ended September 30, 2021
Regulatory Filings
2021-11-11 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2021 ,inter alia, to consider and approve Standalone Unaudited Financial ....
Regulatory Filings
2021-11-01 English
Scrutinizer''s Report
Regulatory Filings
2021-09-30 English
Outcome of AGM
Regulatory Filings
2021-09-30 English
Intimation of closure of Trading Window
Regulatory Filings
2021-09-30 English
Annual Report for the year ended March 31, 2021 along with AGM Notice schedule to be held on September 30, 2021
Regulatory Filings
2021-09-03 English
To Consider and approved Unaudited Standalone Financial Results along with limited review report for the quarter ended June 30, 2021
Regulatory Filings
2021-08-13 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve 1. Standalone Unaudited ....
Regulatory Filings
2021-08-02 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2021-07-28 English
The Trading Window for dealing in the Company''s Equity Shares will remain closed from Thursday, July 1, 2021 for all Designated Employees of the Company. The closure is in connection ....
Regulatory Filings
2021-06-30 English
Disclosure on Related Party Transactions for the year ended March 31, 2021
Regulatory Filings
2021-06-29 English
To considered and approved the Audited Standalone Financial Results for the year ended March 31, 2021
Regulatory Filings
2021-06-29 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve the Standalone Audited Financial ....
Regulatory Filings
2021-06-15 English
Compliance Certificate under Regulation 40(10) - March 2021
Regulatory Filings
2021-04-20 English
Compliance Certificate for the half year ended March 31, 2021
Regulatory Filings
2021-04-15 English
Appointment Mr. Harish Surve as Independent Director
Regulatory Filings
2021-04-15 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2021 ,inter alia, to consider and approve appointment of Independent Director
Regulatory Filings
2021-04-07 English
Intimation of closure of trading window
Regulatory Filings
2021-03-31 English
To considered and approved the Unaudited Standalone Financial Results for the quarter ended December 31, 2020 along with the Limited Review Report.
Regulatory Filings
2021-02-12 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve Standalone unaudited Financial ....
Regulatory Filings
2021-02-01 English